Optimizing heart failure therapy using advanced simulations
Data-driven optimization of therapy for heart failure
['FUNDING_R01'] · UNIVERSITY OF KENTUCKY · NIH-11078696
This study is working on a new tool that helps doctors figure out the best treatments for heart failure by using computer models that predict how your heart might respond to different therapies, making it easier to find the right care just for you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-11078696 on ClinicalTrials.gov |
What this research studies
This research aims to develop a sophisticated simulation framework that predicts how a patient's heart will respond to various therapeutic interventions for heart failure. By integrating engineering, artificial intelligence, and clinical cardiology, the project seeks to create personalized models that can guide clinicians in selecting the most effective treatment options. The framework will be validated with real patient data, allowing for comparisons between model-optimized therapies and standard care. Ultimately, this approach could lead to improved outcomes for patients suffering from heart failure.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with heart failure who may benefit from tailored therapeutic interventions.
Not a fit: Patients with heart failure who are not eligible for therapeutic interventions or those with advanced, untreatable heart conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for patients with heart failure.
How similar studies have performed: Other research has shown promise in using computational models to optimize therapies in cardiology, indicating that this approach could be a significant advancement in the field.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CAMPBELL, KENNETH S — UNIVERSITY OF KENTUCKY
- Study coordinator: CAMPBELL, KENNETH S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.